Literature DB >> 27176554

Pediatric Optic Neuritis Prospective Outcomes Study.

Stacy L Pineles1, Grant T Liu, Amy T Waldman, Elizabeth Lazar, Mark J Kupersmith, Michael X Repka.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27176554      PMCID： PMC6197806          DOI： 10.1097/WNO.0000000000000360

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN： 1070-8022            Impact factor:   3.042


× No keyword cloud information.
  16 in total

1.  Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol.

Authors:  P S Moke; A H Turpin; R W Beck; J M Holmes; M X Repka; E E Birch; R W Hertle; R T Kraker; J M Miller; C A Johnson
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

2.  Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists.

Authors:  Amy T Waldman; Mark P Gorman; Mary R Rensel; Tracy E Austin; Deborah P Hertz; Nancy L Kuntz
Journal:  J Child Neurol       Date:  2011-04-25       Impact factor: 1.987

3.  Visual outcomes in pediatric optic neuritis.

Authors:  Michael J Wan; Olumuyiwa Adebona; Leslie A Benson; Mark P Gorman; Gena Heidary
Journal:  Am J Ophthalmol       Date:  2014-06-05       Impact factor: 5.258

4.  The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists.

Authors:  J D Trobe; P C Sieving; K E Guire; A M Fendrick
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

5.  Risk factors for developing multiple sclerosis after childhood optic neuritis.

Authors:  C F Lucchinetti; L Kiers; A O'Duffy; M R Gomez; S Cross; J A Leavitt; P O'Brien; M Rodriguez
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

Review 6.  Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.

Authors:  G Filippini; F Brusaferri; W A Sibley; A Citterio; G Ciucci; R Midgard; L Candelise
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.

Authors:  Roy W Beck; Jonathan D Trobe; Pamela S Moke; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; Edward G Buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A Goodwin; Barrett Katz; David I Kaufman; John L Keltner; Mark J Kupersmith; Neil R Miller; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Michael Wall
Journal:  Arch Ophthalmol       Date:  2003-07

8.  Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway.

Authors:  Ricarda Diem; Muriel Hobom; Katharina Maier; Robert Weissert; Maria K Storch; Roman Meyer; Mathias Bähr
Journal:  J Neurosci       Date:  2003-08-06       Impact factor: 6.167

9.  Corticosteroids do not prevent optic nerve atrophy following optic neuritis.

Authors:  S J Hickman; R Kapoor; S J Jones; D R Altmann; G T Plant; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

10.  Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.

Authors: 
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079
View more
  2 in total

Review 1.  Pediatric Optic Neuritis: What Is New.

Authors:  Mark Borchert; Grant T Liu; Stacy Pineles; Amy T Waldman
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

2.  Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis.

Authors:  Amy T Waldman; Leslie Benson; John R Sollee; Amy M Lavery; Geraldine W Liu; Ari J Green; Emmanuelle Waubant; Gena Heidary; Darrel Conger; Jennifer Graves; Benjamin Greenberg
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 3.042
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.